Profile

PhD, Boston University School of Medicine
MA, Harvard University
BA, Boston University

Pronouns: she/her/hers
Websites
favorite icon LinkedIn





BU PREP
02/01/2020 - 01/31/2025 (Co-Investigator)
PI: Andrew J. Henderson, PhD
NIH/National Institute of General Medical Sciences
5R25GM125511-05

NSF INCLUDES DDLP: BEST BET: Broadening Experiences in Scientific Training - Beginning Enhancement Track
11/01/2017 - 04/30/2022 (PI)
National Science Foundation
DBI-1744445

Influence of Macrophage NF-kB Activation on the Outcome of Pneumococcal Pneumonia
08/01/2012 - 07/31/2015 (PI)
NIH/National Heart, Lung, and Blood Institute
5F31HL114360-03



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Coleman F. Preprint Highlight: Pathogenic Neutrophilia Drives Acute Respiratory Distress Syndrome in Severe COVID-19 Patients. Mol Biol Cell. 2022 04 01; 33(4):mbcP22021004. PMID: 35319240
     
  2. Murray MP, Crosby CM, Marcovecchio P, Hartmann N, Chandra S, Zhao M, Khurana A, Zahner SP, Clausen BE, Coleman FT, Mizgerd JP, Mikulski Z, Kronenberg M. Stimulation of a subset of natural killer T cells by CD103+ DC is required for GM-CSF and protection from pneumococcal infection. Cell Rep. 2022 01 11; 38(2):110209.View Related Profiles. PMID: 35021099; PMCID: PMC8934033; DOI: 10.1016/j.celrep.2021.110209;
     
  3. Hartmann N, McMurtrey C, Sorensen ML, Huber ME, Kurapova R, Coleman FT, Mizgerd JP, Hildebrand W, Kronenberg M, Lewinsohn DM, Harriff MJ. Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T Cells. Am J Respir Cell Mol Biol. 2018 06; 58(6):767-776.View Related Profiles. PMID: 29356555; PMCID: PMC6002660; DOI: 10.1165/rcmb.2017-0290OC;
     
  4. Coleman FT, Blahna MT, Kamata H, Yamamoto K, Zabinski MC, Kramnik I, Wilson AA, Kotton DN, Quinton LJ, Jones MR, Pelton SI, Mizgerd JP. Capacity of Pneumococci to Activate Macrophage Nuclear Factor ?B: Influence on Necroptosis and Pneumonia Severity. J Infect Dis. 2017 Aug 15; 216(4):425-435.View Related Profiles. PMID: 28368460; PMCID: PMC6279164; DOI: 10.1093/infdis/jix159;
     
  5. Smith NM, Wasserman GA, Coleman FT, Hilliard KL, Yamamoto K, Lipsitz E, Malley R, Dooms H, Jones MR, Quinton LJ, Mizgerd JP. Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. Mucosal Immunol. 2018 Jan; 11(1):220-235.View Related Profiles. PMID: 28513594; PMCID: PMC5693795; DOI: 10.1038/mi.2017.43;
     
  6. Hyatt LD, Wasserman GA, Rah YJ, Matsuura KY, Coleman FT, Hilliard KL, Pepper-Cunningham ZA, Ieong M, Stumpo DJ, Blackshear PJ, Quinton LJ, Mizgerd JP, Jones MR. Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection. PLoS One. 2014; 9(10):e109072.View Related Profiles. PMID: 25299049; PMCID: PMC4192124; DOI: 10.1371/journal.pone.0109072;
     
  7. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun. 2007 Apr; 75(4):1598-608. PMID: 17283089; PMCID: PMC1865697; DOI: 10.1128/IAI.01980-06;
     
  8. Pier GB, Boyer D, Preston M, Coleman FT, Llosa N, Mueschenborn-Koglin S, Theilacker C, Goldenberg H, Uchin J, Priebe GP, Grout M, Posner M, Cavacini L. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol. 2004 Nov 1; 173(9):5671-8. PMID: 15494518
     
  9. Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, Coutinho YS, Noto MJ, Urban TA, Pier GB, Goldberg JB. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect Immun. 2004 Jul; 72(7):4224-32. PMID: 15213167; PMCID: PMC427465
     
  10. Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun. 2003 Jul; 71(7):3875-84. PMID: 12819072; PMCID: PMC162014
     
Showing 10 of 15 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.


Contact for Mentoring:

Media Mentions
_